抗血栓療法

抗血栓療法を考えましょう

[TIMI Study Group @TIMIStudyGroup]

ANGPTL4 inhibition appears to reduce triglycerides. Dr. Michelle O'Donoghue discusses the TYDAL-TIMI 78 trial Part A results.https://t.co/FfVRdPKsvj @DrM_ODonoghue #AHA

[Shinya Goto @sgoto4]

Prevention of Venous Thromboembolism after Total Hip or Knee Replacement | New England Journal of Medicine https://t.co/Z5MrbIEAzd これまた整形外科手術後のVTE予防にはアスピリンで十分とする論文である。本当なんだろうと思う。

[Shinya Goto @sgoto4]

Prasugrel versus Ticagrelor in Acute Coronary Syndromes | New England Journal of Medicine https://t.co/3SRXohrmkX PCIを受けたACSではチカグレロール戦略もプラスグレル戦略も差がないね！

[Shinya Goto @sgoto4]

ANGPTL4 Inhibition in Adults with Elevated Triglyceride Levels | New England Journal of Medicine https://t.co/vtxHL3GLmO 中性脂肪を下げる薬ができた！心血管イベントはどうかな？

[Shinya Goto @sgoto4]

Rivaroxaban Then Aspirin vs. Aspirin Alone after Total Hip or Knee Arthroplasty | New England Journal of Medicine https://t.co/HdzUTMfDA2 整形外科の術後アスピリン単剤でVTE予防に十分という論文は時々だが継続的に出てくる。きっと本当なのだろう！

[Duke Clinical Research Institute @DCRINews]

From the diaphragm to the nervous system, researchers are exploring new ways to treat heart failure with electrical therapies.

DCRI's @FudimMarat reviewed an expanding landscape of device-based approaches and how these could complement GDMT. #ScientificSessions26

[Shinya Goto @sgoto4]

Continued Discussion Regarding the Duration of DAPT after DES implantation https://t.co/pRk4xnRJMh DES留置後の抗血小板薬の継続期間に関するView Pointを発表しました！

[Circulation 日本版 @Circulation_nih]

Hyperaldosteronism Remission after Extended Aldosterone Synthase Inhibition | New England Journal of Medicine https://t.co/ZBVdZErIj0 アルドステロン合成阻害薬はよさげだったけどreboundするのかな？

[Circulation 日本版 @Circulation_nih]

Discontinuing Statins in Older Adults without Cardiovascular Disease | New England Journal of Medicine https://t.co/N73tlCUBK7 年取ったらスタチンやめてもいいのかな？

[Duke Clinical Research Institute @DCRINews]

“Mentorship is about you. Sponsorship is about opportunities, and both can be taught.” AHA President and DCRI’s @manesh_patelMD (with his mentor, @HeartBobH) to early-career attendees. Choose mentors who have time and treat feedback as a gift. #Mentorship #ScientificSessions26

[J-CLEAR（NPO法人臨床研究適正評価教育機構） @NPOJCLEAR]

記事🔗 https://t.co/YiTt3cDA5i

[JAMACardiolJapan @JamaJapan]

2026年11月6日 https://t.co/99MxTPIq6p @YouTubeより厄祓い！

[TIMI Study Group @TIMIStudyGroup]

In 24 hrs in Moderated Digital Poster 21, Population Science Zone, @ebohula presents #Evolocumab for Stroke Prevention in VESALIUS-CV (TIMI 66) #AHA26

[TIMI Study Group @TIMIStudyGroup]

TIMI investigator @DrM_Odonoghue is a panelist in the session, "Rethinking Coronary Revascularization: Less Invasive and More Strategic", tomorrow at 4:45 in S105D #AHA26

[Circulation 日本版 @Circulation_nih]

TAVR in Patients with Moderate Aortic Stenosis with At-Risk Features | New England Journal of Medicine https://t.co/ehPuZ3juuP TAVIの症例は今でも待ちが出るほどの人気だけどmoderate ASまで適応が膨らめば、今の循環器のカテ屋の多くがTAVI屋にならないと対応できないよ！

[Shinya Goto @sgoto4]

Immediate Ambulatory Electrocardiographic Monitoring in Syncope | New England Journal of Medicine https://t.co/mSY4ZtxKAJ 原因不明の失神患者に14日のモニタリングしても原因は究明できない？、驚きの結果でした。

[Circulation 日本版 @Circulation_nih]

祖父が孫に語る独立自尊の重要性ー独立自尊は社会主義とは対極的な思想である！ー｜sgoto3 https://t.co/Fl863Q0iJr 君たちは、私有財産を作り、拡大し、守ることに全力を尽くすのだ。個人としても社会としても独立自尊を目指すとよい。

[Circulation 日本版 @Circulation_nih]

Coronary CT Angiography versus Intravascular Ultrasound Guidance for PCI | New England Journal of Medicine https://t.co/1ve12Rihjr IVUS guidedでなくてもCTガイドでPCIの結果が悪くないとなるとIVUS使うヒト減るかな？

[European Society of Cardiology @escardio]

Ready to share your cardiovascular pharmacotherapy research?

European Heart Journal – Cardiovascular Pharmacotherapy welcomes original clinical, epidemiological, and translational research advancing our understanding of cardiovascular drug therapy.

From clinical trials and real-world studies to drug safety, pharmacogenomics, and pharmacoeconomics, share your research with the international cardiovascular community.

Read the advance articles 👓 https://t.co/3uwAMk6nz0

Submit your paper here 👉 https://t.co/5nsqgkH50b

#EHJPharmacotherapy @AgewallStefan @FeliceGragnano @EditorEHJCVP

[Shinya Goto @sgoto4]

理系に行くか？文系に行くか？：　現在日本では理系はつらいよ！という話｜sgoto3 https://t.co/2COswS4LoC 理系に進学すると、1)大学院の4-8年余分の学費, 2)生活ギリギリ社会保障なしのポスドクの数年, 3)1件あたり20−３０万円の論文出版費用などの不利がある。日本の社会構造が変わらないとこない